Global Specific Cancer Immunotherapy Drugs Sales Market Report Forecast 2017-2021

May 2017 | 105 pages | ID: G721253FC46EN
S&P Consulting

Abstracts

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:

United States
China
Europe
Japan

The Major players reported in the market include:

Amgen
Roche
Bristol Myers Squibb
Dendreon (Valeant)
Novartis
Seattle Genetics
Hangzhou Jinjiang Group
company 8
company 9

Product Segment Analysis:

Tablet
Injection
Type 3

Application Segment Analysis:

Leukemia Treatment
Colorectal Cancer Treatment
Other Cancer Treatment

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides distinctive graphics and exemplified analysis of major market segments

Contents

Global Specific Cancer Immunotherapy Drugs Sales Market Report Forecast 2017-2021

1 SPECIFIC CANCER IMMUNOTHERAPY DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Specific Cancer Immunotherapy Drugs
1.2 Classification of Specific Cancer Immunotherapy Drugs
  1.2.1 Tablet
  1.2.2 Injection
  1.2.3 Type
1.3 Application of Specific Cancer Immunotherapy Drugs
  1.3.2 Leukemia Treatment
  1.3.3 Colorectal Cancer Treatment
  1.3.4 Other Cancer Treatment
1.4 Specific Cancer Immunotherapy Drugs Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Specific Cancer Immunotherapy Drugs (2012-2021)
  1.5.1 Global Specific Cancer Immunotherapy Drugs Sales and Growth Rate (2012-2021)
  1.5.2 Global Specific Cancer Immunotherapy Drugs Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON SPECIFIC CANCER IMMUNOTHERAPY DRUGS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 SPECIFIC CANCER IMMUNOTHERAPY DRUGS MANUFACTURING COST ANALYSIS

3.1 Specific Cancer Immunotherapy Drugs Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Specific Cancer Immunotherapy Drugs

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Specific Cancer Immunotherapy Drugs Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Specific Cancer Immunotherapy Drugs Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL SPECIFIC CANCER IMMUNOTHERAPY DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Specific Cancer Immunotherapy Drugs Market Competition by Manufacturers
  5.1.1 Global Specific Cancer Immunotherapy Drugs Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Specific Cancer Immunotherapy Drugs Revenue and Share by Manufacturers (2012-2017)
5.2 Global Specific Cancer Immunotherapy Drugs (Volume and Value) by Type
  5.5.1 Global Specific Cancer Immunotherapy Drugs Sales and Market Share by Type (2012-2017)
  5.5.2 Global Specific Cancer Immunotherapy Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Specific Cancer Immunotherapy Drugs (Volume and Value) by Regions
  5.3.1 Global Specific Cancer Immunotherapy Drugs Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Specific Cancer Immunotherapy Drugs Revenue and Market Share by Regions (2012-2017)
5.4 Global Specific Cancer Immunotherapy Drugs (Volume) by Application

6 UNITED STATES SPECIFIC CANCER IMMUNOTHERAPY DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 United States Specific Cancer Immunotherapy Drugs Sales and Value (2012-2017)
  6.1.1 United States Specific Cancer Immunotherapy Drugs Sales and Growth Rate (2012-2017)
  6.1.2 United States Specific Cancer Immunotherapy Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 United States Specific Cancer Immunotherapy Drugs Sales Price Trend (2012-2017)
6.2 United States Specific Cancer Immunotherapy Drugs Sales and Market Share by Manufacturers
6.3 United States Specific Cancer Immunotherapy Drugs Sales and Market Share by Type
6.4 United States Specific Cancer Immunotherapy Drugs Sales and Market Share by Application

7 CHINA SPECIFIC CANCER IMMUNOTHERAPY DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 China Specific Cancer Immunotherapy Drugs Sales and Value (2012-2017)
  7.1.1 China Specific Cancer Immunotherapy Drugs Sales and Growth Rate (2012-2017)
  7.1.2 China Specific Cancer Immunotherapy Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 China Specific Cancer Immunotherapy Drugs Sales Price Trend (2012-2017)
7.2 China Specific Cancer Immunotherapy Drugs Sales and Market Share by Manufacturers
7.3 China Specific Cancer Immunotherapy Drugs Sales and Market Share by Type
7.4 China Specific Cancer Immunotherapy Drugs Sales and Market Share by Application

8 EUROPE SPECIFIC CANCER IMMUNOTHERAPY DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Specific Cancer Immunotherapy Drugs Sales and Value (2012-2017)
  8.1.1 Europe Specific Cancer Immunotherapy Drugs Sales and Growth Rate (2012-2017)
  8.1.2 Europe Specific Cancer Immunotherapy Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Specific Cancer Immunotherapy Drugs Sales Price Trend (2012-2017)
8.2 Europe Specific Cancer Immunotherapy Drugs Sales and Market Share by Manufacturers
8.3 Europe Specific Cancer Immunotherapy Drugs Sales and Market Share by Type
8.4 Europe Specific Cancer Immunotherapy Drugs Sales and Market Share by Application

9 JAPAN SPECIFIC CANCER IMMUNOTHERAPY DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Specific Cancer Immunotherapy Drugs Sales and Value (2012-2017)
  9.1.1 Japan Specific Cancer Immunotherapy Drugs Sales and Growth Rate (2012-2017)
  9.1.2 Japan Specific Cancer Immunotherapy Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Specific Cancer Immunotherapy Drugs Sales Price Trend (2012-2017)
9.2 Japan Specific Cancer Immunotherapy Drugs Sales and Market Share by Manufacturers
9.3 Japan Specific Cancer Immunotherapy Drugs Sales and Market Share by Type
9.4 Japan Specific Cancer Immunotherapy Drugs Sales and Market Share by Application

10 GLOBAL SPECIFIC CANCER IMMUNOTHERAPY DRUGS MANUFACTURERS ANALYSIS

10.1 Amgen
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Roche
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Bristol Myers Squibb
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Dendreon (Valeant)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Novartis
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Seattle Genetics
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Hangzhou Jinjiang Group
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 company
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 company
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL SPECIFIC CANCER IMMUNOTHERAPY DRUGS MARKET FORECAST (2017-2021)

13.1 Global Specific Cancer Immunotherapy Drugs Sales, Revenue Forecast (2017-2021)
13.2 Global Specific Cancer Immunotherapy Drugs Sales Forecast by Regions (2017-2021)
13.3 Global Specific Cancer Immunotherapy Drugs Sales Forecast by Type (2017-2021)
13.4 Global Specific Cancer Immunotherapy Drugs Sales Forecast by Application (2017-2021)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Specific Cancer Immunotherapy Drugs
Table Classification of Specific Cancer Immunotherapy Drugs
Figure Global Sales Market Share of Specific Cancer Immunotherapy Drugs by Type in 2015
Table Applications of Specific Cancer Immunotherapy Drugs
Figure Global Sales Market Share of Specific Cancer Immunotherapy Drugs by Application in 2015
Figure United States Specific Cancer Immunotherapy Drugs Revenue and Growth Rate (2012-2021)
Figure China Specific Cancer Immunotherapy Drugs Revenue and Growth Rate (2012-2021)
Figure Europe Specific Cancer Immunotherapy Drugs Revenue and Growth Rate (2012-2021)
Figure Japan Specific Cancer Immunotherapy Drugs Revenue and Growth Rate (2012-2021)
Figure Global Specific Cancer Immunotherapy Drugs Sales and Growth Rate (2012-2021)
Figure Global Specific Cancer Immunotherapy Drugs Revenue and Growth Rate (2012-2021)
Table Global Specific Cancer Immunotherapy Drugs Sales of Key Manufacturers (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Sales Share by Manufacturers (2012-2017)
Figure 2015 Specific Cancer Immunotherapy Drugs Sales Share by Manufacturers
Figure 2016 Specific Cancer Immunotherapy Drugs Sales Share by Manufacturers
Table Global Specific Cancer Immunotherapy Drugs Revenue by Manufacturers (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Specific Cancer Immunotherapy Drugs Revenue Share by Manufacturers
Table 2016 Global Specific Cancer Immunotherapy Drugs Revenue Share by Manufacturers
Table Global Specific Cancer Immunotherapy Drugs Sales and Market Share by Type (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Specific Cancer Immunotherapy Drugs by Type (2012-2017)
Figure Global Specific Cancer Immunotherapy Drugs Sales Growth Rate by Type (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Revenue and Market Share by Type (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Specific Cancer Immunotherapy Drugs by Type (2012-2017)
Figure Global Specific Cancer Immunotherapy Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Sales and Market Share by Regions (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Sales Share by Regions (2012-2017)
Figure Sales Market Share of Specific Cancer Immunotherapy Drugs by Regions (2012-2017)
Figure Global Specific Cancer Immunotherapy Drugs Sales Growth Rate by Regions (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Revenue and Market Share by Regions (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Specific Cancer Immunotherapy Drugs by Regions (2012-2017)
Figure Global Specific Cancer Immunotherapy Drugs Revenue Growth Rate by Regions (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Sales and Market Share by Application (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Specific Cancer Immunotherapy Drugs by Application (2012-2017)
Figure Global Specific Cancer Immunotherapy Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Specific Cancer Immunotherapy Drugs Sales and Growth Rate (2012-2017)
Figure United States Specific Cancer Immunotherapy Drugs Revenue and Growth Rate (2012-2017)
Figure United States Specific Cancer Immunotherapy Drugs Sales Price Trend (2012-2017)
Table United States Specific Cancer Immunotherapy Drugs Sales by Manufacturers (2012-2017)
Table United States Specific Cancer Immunotherapy Drugs Market Share by Manufacturers (2012-2017)
Table United States Specific Cancer Immunotherapy Drugs Sales by Type (2012-2017)
Table United States Specific Cancer Immunotherapy Drugs Market Share by Type (2012-2017)
Table United States Specific Cancer Immunotherapy Drugs Sales by Application (2012-2017)
Table United States Specific Cancer Immunotherapy Drugs Market Share by Application (2012-2017)
Figure China Specific Cancer Immunotherapy Drugs Sales and Growth Rate (2012-2017)
Figure China Specific Cancer Immunotherapy Drugs Revenue and Growth Rate (2012-2017)
Figure China Specific Cancer Immunotherapy Drugs Sales Price Trend (2012-2017)
Table China Specific Cancer Immunotherapy Drugs Sales by Manufacturers (2012-2017)
Table China Specific Cancer Immunotherapy Drugs Market Share by Manufacturers (2012-2017)
Table China Specific Cancer Immunotherapy Drugs Sales by Type (2012-2017)
Table China Specific Cancer Immunotherapy Drugs Market Share by Type (2012-2017)
Table China Specific Cancer Immunotherapy Drugs Sales by Application (2012-2017)
Table China Specific Cancer Immunotherapy Drugs Market Share by Application (2012-2017)
Figure Europe Specific Cancer Immunotherapy Drugs Sales and Growth Rate (2012-2017)
Figure Europe Specific Cancer Immunotherapy Drugs Revenue and Growth Rate (2012-2017)
Figure Europe Specific Cancer Immunotherapy Drugs Sales Price Trend (2012-2017)
Table Europe Specific Cancer Immunotherapy Drugs Sales by Manufacturers (2012-2017)
Table Europe Specific Cancer Immunotherapy Drugs Market Share by Manufacturers (2012-2017)
Table Europe Specific Cancer Immunotherapy Drugs Sales by Type (2012-2017)
Table Europe Specific Cancer Immunotherapy Drugs Market Share by Type (2012-2017)
Table Europe Specific Cancer Immunotherapy Drugs Sales by Application (2012-2017)
Table Europe Specific Cancer Immunotherapy Drugs Market Share by Application (2012-2017)
Figure Japan Specific Cancer Immunotherapy Drugs Sales and Growth Rate (2012-2017)
Figure Japan Specific Cancer Immunotherapy Drugs Revenue and Growth Rate (2012-2017)
Figure Japan Specific Cancer Immunotherapy Drugs Sales Price Trend (2012-2017)
Table Japan Specific Cancer Immunotherapy Drugs Sales by Manufacturers (2012-2017)
Table Japan Specific Cancer Immunotherapy Drugs Market Share by Manufacturers (2012-2017)
Table Japan Specific Cancer Immunotherapy Drugs Sales by Type (2012-2017)
Table Japan Specific Cancer Immunotherapy Drugs Market Share by Type (2012-2017)
Table Japan Specific Cancer Immunotherapy Drugs Sales by Application (2012-2017)
Table Japan Specific Cancer Immunotherapy Drugs Market Share by Application (2012-2017)
Table Amgen Basic Information List
Table Amgen Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Specific Cancer Immunotherapy Drugs Global Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Specific Cancer Immunotherapy Drugs Global Market Share (2012-2017)
Table Bristol Myers Squibb Basic Information List
Table Bristol Myers Squibb Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bristol Myers Squibb Specific Cancer Immunotherapy Drugs Global Market Share (2012-2017)
Table Dendreon (Valeant) Basic Information List
Table Dendreon (Valeant) Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Dendreon (Valeant) Specific Cancer Immunotherapy Drugs Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Specific Cancer Immunotherapy Drugs Global Market Share (2012-2017)
Table Seattle Genetics Basic Information List
Table Seattle Genetics Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Seattle Genetics Specific Cancer Immunotherapy Drugs Global Market Share (2012-2017)
Table Hangzhou Jinjiang Group Basic Information List
Table Hangzhou Jinjiang Group Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hangzhou Jinjiang Group Specific Cancer Immunotherapy Drugs Global Market Share (2012-2017)
Table company 8 Basic Information List
Table company 8 Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 8 Specific Cancer Immunotherapy Drugs Global Market Share (2012-2017)
Table company 9 Basic Information List
Table company 9 Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 9 Specific Cancer Immunotherapy Drugs Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Specific Cancer Immunotherapy Drugs
Figure Manufacturing Process Analysis of Specific Cancer Immunotherapy Drugs
Figure Specific Cancer Immunotherapy Drugs Industrial Chain Analysis
Table Raw Materials Sources of Specific Cancer Immunotherapy Drugs Major Manufacturers in 2015
Table Major Buyers of Specific Cancer Immunotherapy Drugs
Table Distributors/Traders List
Figure Global Specific Cancer Immunotherapy Drugs Sales and Growth Rate Forecast (2017-2021)
Figure Global Specific Cancer Immunotherapy Drugs Revenue and Growth Rate Forecast (2017-2021)
Table Global Specific Cancer Immunotherapy Drugs Sales Forecast by Regions (2017-2021)
Table Global Specific Cancer Immunotherapy Drugs Sales Forecast by Type (2017-2021)
Table Global Specific Cancer Immunotherapy Drugs Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

Amgen, Roche, Bristol Myers Squibb, Dendreon (Valeant), Novartis, Seattle Genetics, Hangzhou Jinjiang Group